CRDL

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Cardiol Therapeutics Inc Class A

NASDAQ | CRDL

1.37

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 22, 2025)

$113.41M

Market Cap

-

P/E Ratio

-0.34

EPS

$2.24

52 Week High

$0.77

52 Week Low

HEALTHCARE

Sector

CRDL Chart

Recent Chart
Price Action

CRDL Technicals

Tags:

CRDL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CAD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$40M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $1.2M
Interest Income $1.2M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $162K
Income Before Tax -$37M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$37M
Comprehensive Income Net Of Tax -
Ebit -$40M
Ebitda -$40M
Net Income -$37M

Revenue & Profitability

Earnings Performance

CRDL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CAD)
Total Assets $32M
Total Current Assets $32M
Cash And Cash Equivalents At Carrying Value $31M
Cash And Short Term Investments $31M
Inventory -
Current Net Receivables $362K
Total Non Current Assets $196K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $727K
Other Non Current Assets -
Total Liabilities $7.1M
Total Current Liabilities $7M
Current Accounts Payable $7M
Deferred Revenue -
Current Debt -
Short Term Debt $33K
Total Non Current Liabilities $126K
Capital Lease Obligations $159K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $159K
Other Current Liabilities $7M
Other Non Current Liabilities -
Total Shareholder Equity $25M
Treasury Stock -
Retained Earnings -$179M
Common Stock $179M
Common Stock Shares Outstanding $72M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CAD)
Operating Cashflow -$25M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $373K
Capital Expenditures $21K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$21K
Cashflow From Financing $19M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$37M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CAD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$40M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $1.2M
Interest Income $1.2M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $162K
Income Before Tax -$37M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$37M
Comprehensive Income Net Of Tax -
Ebit -$40M
Ebitda -$40M
Net Income -$37M

CRDL News

CRDL Profile

Cardiol Therapeutics Inc Class A Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Cardiol Therapeutics Inc. (CRDL) is a clinical-stage biotechnology company headquartered in Oakville, Canada, focusing on the development of innovative anti-inflammatory therapies for cardiovascular diseases (CVD). With a strong pipeline supported by advanced research and development efforts, the company is committed to addressing pressing unmet medical needs in CVD treatment. By harnessing leading-edge science and expertise in inflammation, Cardiol Therapeutics aims to deliver novel therapeutic solutions that have the potential to significantly improve patient outcomes globally.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
RGTI
-7.64%
$40.00
CAN
-4.87%
$1.95
BENF
+75.66%
$0.85
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
NVTS
-12.10%
$15.03
ETHD
-0.80%
$3.72
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
WTO
+2.93%
$0.06
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
EPWK
-8.71%
$0.07
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
AG
-11.21%
$12.75
PSTV
+6.93%
$0.61
WULF
-5.12%
$13.14
INFY
+2.95%
$17.41
CORZ
+2.23%
$19.23
CRWV
-1.57%
$125.06
UAMY
-7.74%
$12.39
CDE
-16.11%
$18.48
AFMD
-34.94%
$0.18
NEHC
-23.22%
$4.33
NUAI
-23.22%
$4.33
NGD
-11.68%
$6.35
DNUT
+13.80%
$3.71
OKLO
-12.32%
$139.44
RYOJ
+140.00%
$9.11
QS
-3.84%
$15.52
HOLX
+2.93%
$73.98
KGC
-11.02%
$23.07
CRML
-16.90%
$16.27
ABAT
-9.22%
$6.10
STLA
+4.02%
$11.12
PCG
+0.41%
$16.75
CSX
-2.56%
$35.72
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
RGTI
-7.64%
$40.00
CAN
-4.87%
$1.95
BENF
+75.66%
$0.85
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
NVTS
-12.10%
$15.03
ETHD
-0.80%
$3.72
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
WTO
+2.93%
$0.06
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
EPWK
-8.71%
$0.07
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
AG
-11.21%
$12.75
PSTV
+6.93%
$0.61
WULF
-5.12%
$13.14
INFY
+2.95%
$17.41
CORZ
+2.23%
$19.23
CRWV
-1.57%
$125.06
UAMY
-7.74%
$12.39
CDE
-16.11%
$18.48
AFMD
-34.94%
$0.18
NEHC
-23.22%
$4.33
NUAI
-23.22%
$4.33
NGD
-11.68%
$6.35
DNUT
+13.80%
$3.71
OKLO
-12.32%
$139.44
RYOJ
+140.00%
$9.11
QS
-3.84%
$15.52
HOLX
+2.93%
$73.98
KGC
-11.02%
$23.07
CRML
-16.90%
$16.27
ABAT
-9.22%
$6.10
STLA
+4.02%
$11.12
PCG
+0.41%
$16.75
CSX
-2.56%
$35.72
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.